The MSL, Oncology (Lung and/or Head & Neck Cancers) will join a fast-growing Field Medical Affairs team focused on commercializing the novel Signatera™ molecular residual disease test to oncologists and cancer researchers across solid tumors, with particular emphasis on lung and/or head and neck cancers, along with complementary products and services in Natera’s oncology portfolio. In 2019, the FDA designated Signatera as a Breakthrough Device, and Medicare proposed to cover its use in patients with Stage II–III colorectal cancer as its first covered indication. We are looking for a smart, mission-oriented Medical Affairs professional who can communicate effectively and help us transform the management of cancer worldwide. The Medical Science Liaison (MSL) serves as a key field-based scientific resource for clinicians, academic institutions, and professional organizations.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree